Tiefenbacher Group is a leading healthcare company in Germany, with a history dating back to 1963. The company operates along the entire pharmaceutical value chain, specializing in the distribution of APIs, as well as the development, manufacturing, and registration of finished dosage forms.
With a global presence that includes laboratories and manufacturing sites, Tiefenbacher Group is committed to making pharmaceuticals more affordable, available, and effective. Their innovative solutions have earned them the trust of the world's most renowned brands, showcasing their pioneer spirit and pharmaceutical excellence.
With over 800 dedicated employees, the company aims to improve the lives of millions of patients worldwide. Tiefenbacher Group's dedication to pioneering healthcare is evident in their slogan, reflecting their steadfast commitment to shaping the future of health.
As a 100% family-owned business, Tiefenbacher Group continues to make significant strides in the healthcare and pharmaceutical industries, and their unwavering focus on innovation and impact positions them as a noteworthy player in the sector.
There is no investment information
No recent news or press coverage available for Tiefenbacher Group.